Loading...
How to connect an IgE-driven response with CTL activity?
One of the goals of cell-based immune therapy in cancer is the induction of tumor-specific cytotoxic T-lymphocyte (CTL) responses. To achieve this objective, the ability of dendritic cells (DC) to cross-present tumor antigens can be exploited. One of the most efficient pathways for the induction of...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3299812/ https://ncbi.nlm.nih.gov/pubmed/22042251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-011-1127-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|